Par-4 prevents breast cancer recurrence

被引：2

作者：

Hebbar, Nikhil ^{[1
]}

Shrestha-Bhattarai, Tripti ^{[1
]}

Rangnekar, Vivek M. ^{[1
,2
,3
,4
,5
]}

机构：

[1] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA

[2] Univ Kentucky, Dept Radiat Med, Lexington, KY 40536 USA

[3] Univ Kentucky, Dept Microbiol Immunol, Lexington, KY 40536 USA

[4] Univ Kentucky, Dept Mol Genet, Lexington, KY 40536 USA

[5] Univ Kentucky, LP Markey Canc Ctr, Lexington, KY USA

来源：

BREAST CANCER RESEARCH | 2013年 / 15卷 / 05期

基金：

美国国家卫生研究院;

关键词：

DOWN-REGULATION; APOPTOSIS; GENE;

D O I：

10.1186/bcr3562

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Therapy resistance and disease recurrence are two of the most challenging aspects in breast cancer treatment. A recent article in Cancer Cell makes a significant contribution toward a better understanding of this therapeutic problem by establishing downregulation of the tumor suppressor Par-4 as the primary determinant of breast cancer recurrence. This viewpoint brings forth the importance of their findings and its implications on future research and therapy.

引用

页数：2

共 50 条

[1] Par-4 prevents breast cancer recurrence
Nikhil Hebbar
Tripti Shrestha-Bhattarai
Vivek M Rangnekar
Breast Cancer Research, 15
[2] Par-4 Downregulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy
Alvarez, James V.
Pan, Tien-chi
Ruth, Jason
Feng, Yi
Zhou, Alice
Pant, Dhruv
Grimley, Joshua S.
Wandless, Thomas J.
DeMichele, Angela
Chodosh, Lewis A.
CANCER CELL, 2013, 24 (01) : 30 - 44
[3] Role of PAR-4 in ovarian cancer
Meynier, Sonia
Kramer, Marianne
Ribaux, Pascale
Tille, Jean-Christophe
Delie, Florence
Petignat, Patrick
Cohen, Marie
ONCOTARGET, 2015, 6 (26) : 22641 - 22652
[4] Par-4 as therapy for colon cancer
Irby, Rosalyn B.
Kline, Christina L.
Sharma, Arun K.
CANCER RESEARCH, 2010, 70
[5] Gastrin signaling and Par-4 in pancreatic cancer
Fino, Kristin K.
Irby, Rosalyn B.
Smith, Jill P.
CANCER RESEARCH, 2011, 71
[6] Radiosensitivity with Par-4 expression in prostate cancer
Sheikh, MS
CANCER BIOLOGY & THERAPY, 2002, 1 (02) : 161 - 162
[7] Par-4 as a potential target for cancer therapy
Irby, Rosalyn B.
Kline, Christina L. B.
EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (01) : 77 - 87
[8] Apoptosis by Par-4 in cancer and neurodegenerative diseases
El-Guendy, N
Rangnekar, VM
EXPERIMENTAL CELL RESEARCH, 2003, 283 (01) : 51 - 66
[9] Par-4 for molecular therapy of prostate cancer
Butler, J
Rangnekar, VM
CURRENT DRUG TARGETS, 2003, 4 (03) : 223 - 230
[10] Regulation of cancer cell survival by Par-4
Ranganathan, P
Rangnekar, VM
TUMOR PROGRESSION AND THERAPEUTIC RESISTANCE, 2005, 1059 : 76 - 85

← 1 2 3 4 5 →